Peter Byrne

Partner
Full contact info

Experience

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, New York
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington, DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington, DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington, DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

Lavoro to Become Publicly Traded Through Business Combination With TPB Acquisition Corporation I

April 24, 2023

Cooley advised TPB Acquisition Corporation I, a special purpose acquisition company sponsored by The Production Board, in its business combination agreement that will result in Lavoro Limited, a leading agricultural inputs retailer in Latin America, becoming a US publicly listed company with an implied initial enterprise value of approximately $1.2 billion.

Read more

Related contacts

Garth Angelo Osterman
Partner, San Francisco
Rachel Proffitt
Partner and Chief Executive Officer, San Francisco
Peter Byrne
Partner, New York
Kristin VanderPas
Partner, San Francisco
Michelle Peleg
Associate, San Francisco
Sarah Curry
Associate, New York
Jesse Schulman
Associate, Washington, DC
Wesley Dietrich
Associate, Washington, DC
Yoana Setzer
Associate, New York
Aaron Pomeroy
Partner, Colorado
Courtney M.W. Tygesson
Partner, Chicago
Todd Gluth
Partner, San Diego
Calvin Lee
Associate, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Jill Simon
Senior Paralegal, New York

Related Practices & Industries

Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II

December 9, 2021

Cooley advised Alvotech Holdings, a global biopharmaceutical company focused on the development and manufacturing of biosimilar medicines for patients worldwide, on its agreement to merge with special purpose acquisition company (SPAC) Oaktree Acquisition Corp. II. Lawyers Michal Berkner, Div Gupta, Nicolas Dumont and Jarrett Burks led the Cooley team advising Alvotech.

Read more

Related contacts

Div Gupta
Partner, New York
Nicolas H.R. Dumont
Partner, New York
Jarrett Burks
Associate, London
Vlad Herta
Associate, London
Wouter Deleersnyder
Associate, New York
Sonia Nath
Partner, Washington, DC
Elizabeth Anne Wright
Partner, Brussels
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Barbara Mirza
Partner, Los Angeles Santa Monica
Stacey A. Bradford
Special Counsel, Washington, DC
Rick Jantz
Associate, Los Angeles Santa Monica
Stella Sarma
Special Counsel, Brussels
Jennifer Shanley
Special Counsel, New York
Ivor Elrifi
Partner, New York
Sharon Connaughton
Special Counsel, Washington, DC
David Boles
Partner, London
Alexandria Ashour
Associate, San Diego
Chris Coulter
Partner, London
David Dalton
Associate, Los Angeles Santa Monica
Neelam Atwal
Associate, London
Chris Stack
Partner, London
Alan W. Tamarelli
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Wyatt Kernell
Associate, New York
Reid Hooper
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Sanya Sukduang
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
James Maton
Partner, London
Shehzad Akram
Trainee Solicitor , London
Sarah Oliai
Associate, Washington, DC
Barbara Borden
Partner, San Diego
Nicola Squire
Partner, London
Peter Byrne
Partner, New York
Claire Keast-Butler
Partner, London
Jill Simon
Senior Paralegal, New York
Xander Lee
Partner, Los Angeles Santa Monica
Calvin Lee
Associate, New York

Related Practices & Industries

Braze – $572 Million IPO

November 24, 2021

Cooley advised customer engagement platform Braze on its $572 million initial public offering of 8,800,000 shares of Class A common stock, which now trade on the Nasdaq Global Select Market under the symbol BRZE. Lawyers Nicole Brookshire, Jodie Bourdet, Peter Byrne and Owen Williams led the team advising Braze.

Read more

Related contacts

Jodie Bourdet
Partner, San Francisco
Peter Byrne
Partner, New York
Sacha Ross
Partner, New York
Andrew Gunther
Associate, New York
Jayne M. Munger
Associate, New York
Jill Simon
Senior Paralegal, New York
Jason Minio
Paralegal Specialist, Boston
Cathy Rude
Paralegal Specialist, Boston
Megan Browdie
Partner, Washington, DC
Rubin Waranch
Associate, Washington, DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Paula Holland
Partner, London
Nicola Squire
Partner, London
Wendy Brenner
Partner, Palo Alto
Amis Pan
Associate, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Len Jacoby
Partner, New York
Eileen Marshall
Partner, Washington, DC
Stephanie Gentile
Partner, New York
David Navetta
Partner, Colorado
Claire Gibbs
Associate, Washington, DC
Amy Collins
Special Counsel, London
Francis Wheeler
Partner, Colorado

Related Practices & Industries